OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Vitiligo Skin T Cells Are Prone to Produce Type 1 and Type 2 Cytokines to Induce Melanocyte Dysfunction and Epidermal Inflammatory Response Through Jak Signaling
Christina Martins, Laure Migayron, Claire Drullion, et al.
Journal of Investigative Dermatology (2021) Vol. 142, Iss. 4, pp. 1194-1205.e7
Open Access | Times Cited: 45

Showing 26-50 of 45 citing articles:

Ruxolitinib Cream 1.5%: A Review in Non-Segmental Vitiligo
Connie Kang
Drugs (2024) Vol. 84, Iss. 5, pp. 579-586
Open Access | Times Cited: 3

Impact of house dust mite in vitiligo skin: environmental contribution to increased cutaneous immunity and melanocyte detachment
Hanene Bzioueche, Katia Boniface, Claire Drullion, et al.
British Journal of Dermatology (2023) Vol. 189, Iss. 3, pp. 312-327
Closed Access | Times Cited: 8

Understanding of Pathomechanisms and Clinical Practice for Vitiligo
Atsushi Tanemura
Annals of Dermatology (2023) Vol. 35, Iss. 5, pp. 333-333
Open Access | Times Cited: 7

Circulating immune cells and vitiligo: a bidirectional two-sample Mendelian randomization study
Yu Xin, Tao Yuan, Jun Wang
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2

From traditional medicine to nanomedicine: Potential of Ginkgo biloba extracts in inflammatory skin diseases
Itisha Chummun Phul, Andrea Gómez-Llonín, Archana Bhaw‐Luximon
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 8, pp. 2643-2656
Closed Access | Times Cited: 2

Ritlecitinib, a JAK3/TEC family kinase inhibitor, stabilizes active lesions and repigments stable lesions in vitiligo
Yuji Yamaguchi, Elena Peeva, Ester Del Duca, et al.
Archives of Dermatological Research (2024) Vol. 316, Iss. 7
Open Access | Times Cited: 1

JAK Inhibitors in Immune Regulation and Treatment of Vitiligo
Kewei Liu, Linyi Zhou, Meihui Shi, et al.
Cytokine & Growth Factor Reviews (2024) Vol. 80, pp. 87-96
Closed Access | Times Cited: 1

Resident memory T cell contributes to the phenotype of inflammatory vitiligo
Ken Okamura, Takanobu Kabasawa, T. Saito, et al.
Journal of Dermatological Science (2024) Vol. 113, Iss. 2, pp. 74-76
Closed Access | Times Cited: 1

Potential Role of Chronic Physical Exercise as a Treatment in the Development of Vitiligo
Elias de França, Ronaldo Vagner Thomatieli dos Santos, Liliana C. Baptista, et al.
Frontiers in Physiology (2022) Vol. 13
Open Access | Times Cited: 6

Baseline Levels of Circulating Inflammatory Biomarkers Stratify Patients with Vitiligo Who Significantly Repigment after Treatment with Ruxolitinib Cream
Michael Howell, Fiona I. Kuo, Beth Rumberger, et al.
JID Innovations (2023) Vol. 3, Iss. 6, pp. 100230-100230
Open Access | Times Cited: 3

Type-2 immunity associated with type-1 related skin inflammatory diseases: friend or foe?
Laure Migayron, Sylvie Bordes, B. Closs, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Vitiligo
Chunying Li, Weinan Guo, Shuli Li, et al.
Elsevier eBooks (2024), pp. 1267-1286
Closed Access

Exploring mechanisms of skin aging: insights for clinical treatment
Meiqi Zhang, Yumeng Lin, Zhongyu Han, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access

Focusing on the Dark Side of the Moon: Involvement of the Nonlesional Skin in Vitiligo
Meri K. Tulić, Daniela Kovacs, Emanuela Bastonini, et al.
Journal of Investigative Dermatology (2024)
Open Access

CLEC12B regulates melanocyte immunity and homeostasis in the skin through the STAT1/IRF1 axis.
Lauriane Blot, Hanene Bzioueche, M. Heim, et al.
Journal of Investigative Dermatology (2024)
Open Access

Aetiopathogenesis of Vitiligo
Katia Boniface
Dermatology Practical & Conceptual (2023), pp. e2023314S-e2023314S
Open Access | Times Cited: 1

JAK inhibitors in vitiligo: what they hit and what they miss - an immunopathogenesis based exposition of existing evidence
Kabir Sardana, Aishwarya Muddebihal, Ananta Khurana
Expert Review of Clinical Pharmacology (2023) Vol. 16, Iss. 12, pp. 1221-1227
Closed Access

Inibidores da via JAK‐STAT na dermatologia
Hélio Amante Miot, Paulo Ricardo Criado, Caio César Silva de Castro, et al.
(2023) Vol. 98, Iss. 5, pp. 656-677
Open Access

A challenge in paediatrics: concurrent atopic dermatitis and vitiligo
Yu. S. Smolkin, В. Н. Красникова, I. M. Korsunskaya
Meditsinskiy sovet = Medical Council (2023), Iss. 12, pp. 151-155
Open Access

Previous Page - Page 2

Scroll to top